{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:39:54Z","timestamp":1772843994221,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.canrad.2022.10.005","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T04:40:01Z","timestamp":1681879201000},"page":"214-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Infection after prostatic transrectal fiducial marker implantation for image guided radiation therapy"],"prefix":"10.1016","volume":"27","author":[{"given":"T.","family":"Reynaud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Ben Aicha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Carignan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pelchat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Fiset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-G.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Vigneault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2022.10.005_bib0165","doi-asserted-by":"crossref","first-page":"E199","DOI":"10.1503\/cmaj.191292","article-title":"Projected estimates of cancer in Canada in 2020","volume":"192","author":"Brenner","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.canrad.2022.10.005_bib0170","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D\u2019Amico","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.canrad.2022.10.005_bib0175","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1016\/j.canrad.2016.07.037","article-title":"Prostate cancer external beam radiotherapy","volume":"20Suppl","author":"de Crevoisier","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2022.10.005_bib0180","doi-asserted-by":"crossref","unstructured":"O\u2019Neill AGM, Jain S, Hounsell AR, O'Sullivan JM. Fiducial marker guided prostate radiotherapy: a review. Br J Radiol n.d.;89. 10.1259\/bjr.20160296.","DOI":"10.1259\/bjr.20160296"},{"key":"10.1016\/j.canrad.2022.10.005_bib0185","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.canrad.2018.06.010","article-title":"La radioth\u00e9rapie externe guid\u00e9e par l\u2019imagerie dans le cancer de la prostate; comment, quand et pourquoi?","volume":"22","author":"Escande","year":"2018","journal-title":"Cancer\/Radioth\u00e9rapie"},{"key":"10.1016\/j.canrad.2022.10.005_bib0190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.radonc.2019.08.027","article-title":"ESTRO ACROP consensus guideline on the use of image guided radiation therapy for localized prostate cancer","volume":"141","author":"Ghadjar","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2022.10.005_bib0195","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0167-8140(03)00078-1","article-title":"Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation","volume":"67","author":"Dehnad","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2022.10.005_bib0200","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ijrobp.2007.04.009","article-title":"Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: complication rate and risk factors","volume":"69","author":"Langenhuijsen","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.10.005_bib0205","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.urology.2007.10.011","article-title":"Technique for implantation of fiducial markers in the prostate","volume":"71","author":"Shinohara","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.canrad.2022.10.005_bib0210","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1440-1673.2008.01978.x","article-title":"Planning and implementing an implanted fiducial programme for prostate cancer radiation therapy","volume":"52","author":"Thompson","year":"2008","journal-title":"J Med Imag Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.10.005_bib0215","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.urology.2008.10.071","article-title":"Technique of outpatient placement of intraprostatic fiducial markers before external beam radiotherapy","volume":"73","author":"Linden","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.canrad.2022.10.005_bib0220","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1259\/bjr\/14201041","article-title":"Implantation of fiducial markers for image guidance in prostate radiotherapy: patient-reported toxicity","volume":"82","author":"Igdem","year":"2009","journal-title":"Br J Radiol"},{"key":"10.1016\/j.canrad.2022.10.005_bib0225","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.gie.2009.03.001","article-title":"EUS-guided fiducial placement before targeted radiation therapy for prostate cancer","volume":"70","author":"Yang","year":"2009","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.canrad.2022.10.005_bib0230","unstructured":"Escudero JUJ, Peidro JP, de Campos MR, Torrecilla JL, Alcina EL, Verdejo PN, et al. Insertion of Intraprostate Gold Fiducial Markers in Prostate Cancer Treatment. Nephro-Urology Monthly\/\/;2:265-72. https:\/\/sites.kowsarpub.com\/num\/articles\/71517.html.(accessed October 13, 2020)."},{"key":"10.1016\/j.canrad.2022.10.005_bib0235","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2010.02.027","article-title":"Long-term experience with transrectal and transperineal implantations of fiducial gold markers in the prostate for position verification in external beam radiotherapy; feasibility, toxicity and quality of life","volume":"96","author":"Moman","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2022.10.005_bib0240","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1754-9485.2011.02278.x","article-title":"Assessment of prostatic fiducial marker introduction: patient morbidity, staff satisfaction and improved treatment field placement","volume":"55","author":"Brown","year":"2011","journal-title":"J Med Imag Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.10.005_bib0245","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1259\/bjr\/68127917","article-title":"Patient-reported complications from fiducial marker implantation for prostate image-guided radiotherapy","volume":"85","author":"Gill","year":"2012","journal-title":"Br J Radiol"},{"key":"10.1016\/j.canrad.2022.10.005_bib0250","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.canrad.2014.07.160","article-title":"Fiducial marker implantation in prostate radiation therapy: Complication rates and technique","volume":"18","author":"Fawaz","year":"2014","journal-title":"Cancer\/Radioth\u00e9rapie"},{"key":"10.1016\/j.canrad.2022.10.005_bib0255","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4081\/aiua.2014.4.349","article-title":"Prostatic fiducial markers implantation by transrectal ultrasound for adaptive image guided radiotherapy in localized cancer: 7-years experience","volume":"86","author":"Lacetera","year":"2014","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.canrad.2022.10.005_bib0260","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jvir.2014.03.017","article-title":"Single-center experience in prostate fiducial marker placement: technique and midterm follow-up","volume":"25","author":"Kably","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.canrad.2022.10.005_bib0265","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13014-015-0347-2","article-title":"Infections after fiducial marker implantation for prostate radiotherapy: are we underestimating the risks?.","volume":"10","author":"Loh","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.10.005_bib0270","doi-asserted-by":"crossref","first-page":"E272","DOI":"10.1016\/j.ijrobp.2016.06.1307","article-title":"Infections after fiducial markers implantation for prostate radiation therapy: optimizing the antimicrobial prophylaxis","volume":"96","author":"Clavel","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.10.005_bib0275","doi-asserted-by":"crossref","first-page":"21","DOI":"10.14338\/IJPT-16-00007.1","article-title":"Bacterial urinary tract infection after transrectal placement of fiducial markers prior to proton radiotherapy for prostate cancer","volume":"3","author":"Mendenhall","year":"2016","journal-title":"Int J Particle Ther"},{"key":"10.1016\/j.canrad.2022.10.005_bib0280","first-page":"e3526","article-title":"Low infection rate after transrectal implantation of Gold Anchor \u2122 fiducial markers in prostate cancer patients after non-broad-spectrum antibiotic prophylaxis","volume":"10","author":"Castellanos","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.canrad.2022.10.005_bib0285","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/COC.0000000000000454","article-title":"Rectal culture and sensitivity analysis for reducing sepsis risk after fiducial marker placement","volume":"41","author":"Mendenhall","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.canrad.2022.10.005_bib0290","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3389\/fonc.2020.00203","article-title":"Prostate fiducial marker placement in patients on anticoagulation: feasibility prior to prostate SBRT","volume":"10","author":"Iocolano","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2022.10.005_bib0295","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.juro.2017.01.103","article-title":"An update of the american urological association white paper on the prevention and treatment of the more common complications related to prostate biopsy","volume":"198","author":"Liss Michael","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2022.10.005_bib0300","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.eururo.2012.04.044","article-title":"Increasing risk of infectious complications after transrectal ultrasound\u2013guided prostate biopsies: time to reassess antimicrobial prophylaxis?","volume":"62","author":"Carignan","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2022.10.005_bib0305","unstructured":"Shigemura K, Fujisawa M. Prevention and management of infectious complications in prostate biopsy: A review. International Journal of Urology n.d.;n\/a. 10.1111\/iju.14572"},{"key":"10.1016\/j.canrad.2022.10.005_bib0310","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41391-018-0092-3","article-title":"Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy","volume":"22","author":"Tan","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.canrad.2022.10.005_bib0315","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4111\/icu.2017.58.5.365","article-title":"Targeted\u201d prophylaxis: impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy","volume":"58","author":"Singh","year":"2017","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.canrad.2022.10.005_bib0320","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/JU.0000000000001399","article-title":"Nonantibiotic strategies for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis","volume":"205","author":"Pradere","year":"2021","journal-title":"J Urol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321823000598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321823000598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:35:46Z","timestamp":1761136546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321823000598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1278321823000598"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2022.10.005","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infection after prostatic transrectal fiducial marker implantation for image guided radiation therapy","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2022.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}